ND

Nick Damiano

Founder of Andromeda Surgical

San Francisco, California

Overview 

Nick Damiano is the CEO & Co-Founder of Andromeda Surgical, a company focused on surgical robots and AI, with notable achievements including participation in Y Combinator S23 & W15. His career highlights include leading a successful startup in the medical devices sector and demonstrating expertise in technological innovation and organizational effectiveness. Damiano's current role as CEO & Co-Founder at Andromeda Surgical showcases his leadership in the development of cutting-edge surgical technology, as well as his track record of success in the startup ecosystem, particularly in the areas of robotics and artificial intelligence.

Work Experience 

  • CEO & Co-Founder

    2023 - Current

    Autonomous surgical robots with initial focus on urology. YC S23

Andromeda Surgical is a developer of autonomous robots intended to make surgery more consistent, error-free, and efficient.

  • Venture Partner

    2017

    Y Combinator alumni venture fund Most active seed investor in the world as per Pitchbook

  • Founder & Advisor

    2022 - 2023

  • CEO & Founder

    2014 - 2022

    Co-invented implantable device for BPH (enlarged prostate) and led company through market readiness. Product has successfully treated > 300 patients in six countries. Raised ~$70M in venture, angel, debt, and grant funding. Hired and led elite team of 28 FTEs. First medtech company funded by Y Combinator (YC W15). Outexecuted all competitors in a crowded space and left company in prime position for successful pivotal trial completion, commercial launch, and exit.

Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.

Raised $80,068,844.00 from Invus Opportunities, Cook Medical, MedTech Venture Partners and F-Prime Capital.

  • Chief Strategy Officer

    2022 - 2023

    A new & more powerful adult pluripotent stem cell platform for hard-to-treat diseases

NOVEL STEM CELL TECHNOLOGY TARGETING UNMET MEDICAL NEEDS

Raised $4,300,000.00 from Beyond Ventures, Magic Capital, Oriza Ventures, Magic Capital, StartX (Stanford-StartX Fund), InnoSpring Seed Fund and Magic Capital.

  • Co-Founder & Advisor

    2014 - 2018

    Company was acquired by Mendaera Formerly known as Nurep

  • Co-Founder & CTO

    2012 - 2014

    Initially known as Nurep, Inc. Telepresence for the operating room. Launched in ~1000 medical facilities. Our goal was to change the outdated system where surgeons could only get expert support from someone physically in the OR. In 2012, nobody believed we could overcome the massive opposition to this paradigm shift. Mission accomplished and it's now the industry standard.

Avail is a dedicated hardware/software platform for the operating room, transforming communication between MedTech and surgical teams.

Raised $127,932,668.00 from 8VC and D1 Capital Partners.

  • Biodesign Fellow Externship

    2014 - 2014

    Went to Delhi to help a medtech company based there with global commercialization strategy

  • Biodesign Innovation Fellow

    2013 - 2014

    World's leading innovation program for medtech

  • Entrepreneur

    2013 - 2013

    Blueprint Health is a Charter Member of the Global Accelerator Network, which was started by TechStars

Blueprint Health is a mentorship-driven startup accelerator program in NYC, supporting entrepreneurs.

  • Research Engineer

    2008 - 2012

    Developed key algorithms for world's first fully functional leadless pacemaker ASX: EBR

EBR Systems is a provider of wireless cardiac pacing system for millions of patients suffering from cardiac rhythm diseases.

Raised $199,857,026.00 from M. H. Carnegie & Co., Brandon Capital, Emergent Medical Partners, Split Rock Partners, Ascension Ventures, M. H. Carnegie & Co., Brandon Capital, Thomas Fogarty, Ascension Ventures and Split Rock Partners.

Articles About Nick

Relevant Websites